Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
U.S. stock index futures gained ground on Monday, as investors looked ahead to an anticipated Federal Reserve interest rate cut later in the week, as well as key data prints that will help set the tone for policy next year. .N
** Novo Nordisk NVO.N:BUZZ - Rises as Catalent deal in US nears nL8N3NH08F
** Tesla TSLA.O:BUZZ - Wedbush sees Tesla market cap to hit $2 trln by end-2025; lifts PT to Street high nL4N3NH0KY
** Super Micro Computer SMCI.O:BUZZ - Plunges on exclusion from Nasdaq 100 nL4N3NH0MA
** MicroStrategy MSTR.O:BUZZ - Jumps as company set to join Nasdaq 100 index nL4N3NH0M8
** Capri Holdings CPRI.N:BUZZ - Jumps after J.P.Morgan hikes PT on 'gradual improvement' at brands nL4N3NH0O8
** Masco Corp MAS.N:BUZZ - Falls after Jefferies cuts to 'hold', lowers PT nL4N3NH0QL
** Checkpoint Therapeutics Inc CKPT.O:BUZZ - Rises after FDA approval of co's skin cancer drug nL4N3NH0QI
** NetApp NTAP.O:BUZZ - Up as JPM raises to 'overweight' on improving IT budgets for AI-led growth nL4N3NH0R7
** Honeywell International HON.O:BUZZ - Shares up after co says considering separation of aerospace business nL4N3NH0Q5
** Edgewise Therapeutics EWTX.O:BUZZ - Gains as genetic disorder drug meets mid-stage study goal nL4N3NH0SQ
** CBRE Group CBRE.N:BUZZ - Rises after J.P. Morgan upgrades to 'overweight' nL4N3NH0TA
** Nike NKE.N:BUZZ - Telsey Advisory cuts Nike's PT on weaker demand trends nL4N3NH0TF
** Ford Motor F.N:BUZZ - Slips after Jefferies cuts to 'underperform' nL4N3NH0WO
** Viridian Therapeutics VRDN.O:BUZZ - Jumps as thyroid eye disease drug meets late-stage study goal nL4N3NH0XF
** Biohaven BHVN.N:BUZZ - Rises on positive early-stage antibody drug trial results nL4N3NH0XQ
** Plby Group PLBY.O:BUZZ - Gains on deal with Byborg Enterprises nL4N3NH0Y3
** Walt Disney Co DIS.N:BUZZ - Parks face short-term challenges against future potential, MoffettNathanson says nL4N3NH0XD
(Compiled by Rajarshi Roy and Neil J Kanatt)
((Neil.JKanatt@thomsonreuters.com))
Comments